Trial
NCT04262869
Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI)
Condition
Lung Non-Small Cell Carcinoma
Intervention
Carboplatin
Why stopped
Due to accrual issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-27